 |
|
|
| |
SVR4 and SVR12 with an interferon-free regimen of BI 201335 AND BI 207127,
+/- ribavirin, in treatment-naïve patients with chronic genotype-1 HCV infection:
Interim results of SOUND-C2
|
| |
| |
Reported by Jules Levin
EASL 2012
Stefan Zeuzem,1 Vicente Soriano,2 Tarik Asselah,3 Jean-Pierre Bronowicki,4
Ansgar W. Lohse,5 Beat Mullhaupt,6 Marcus Schuchmann,7 Marc Bourliere,8
Maria Buti,9 Stuart Roberts,10 Ed Gane,11 Jerry O. Stern,12 George Kukolj,12
Luyan Dai,12 Wulf O. Böcher,13 Federico J. Mensa13
1Klinikum der J. W. Goethe-Universitat, Frankfurt am Main, Germany; 2Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; 3Hopital Beaujon, Clichy, France; 4Hopital de Brabois, Vandoeuvre, France; 5University Hospital Hamburg-Eppendorf, Hamburg; 6University Hospital of Zurich, Zurich, Switzerland; 7University Hospital Mainz, Mainz, Germany; 8Hopital Saint Joseph, Marseille Cedex, France; 9Hospital Vall d'Hebron, Barcelona, Spain; 10Alfred Hospital, Department of Gastroenterology, Melbourne, Australia; 11Auckland Clinical Studies, Auckland, New Zealand; 12Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA; 13Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
|
| |
|
|
|
|
|
